[LRMR] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 62.31%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -35,355 -50,636 -42,482 -23,132 -62,968 -52,928 -58,178 -7.96%
Tax -1,171 -326 -155 -94 -1,600 -900 -300 25.46%
NP -34,184 -50,310 -42,327 -23,132 -61,368 -52,028 -57,878 -8.39%
Tax Rate - - - - - - - -
Total Cost 34,184 50,310 42,327 23,132 61,368 52,028 57,878 -8.39%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -38.83%
EPS Diluted -1.33 -2.93 -3.56 -2.51 -22.85 -22.76 -25.44 -38.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.